نتایج جستجو برای: nvp

تعداد نتایج: 1232  

2014
Laia Rosich Arnau Montraveta Sílvia Xargay-Torrent Mónica López-Guerra Jocabed Roldán Marta Aymerich Itziar Salaverria Sílvia Beà Elías Campo Patricia Pérez-Galán Gaël Roué Dolors Colomer

Phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway activation contributes to mantle cell lymphoma (MCL) pathogenesis and drug resistance. Antitumor activity has been observed with mTOR inhibitors. However, they have shown limited clinical efficacy in relation to drug activation of feedback loops. Selective PI3K inhibition or dual PI3K/mTOR catalytic inhibition...

2011
Chintda Santiskulvong Gottfried E. Konecny Mirela Fekete Kuang-Yui Michael Chen Amer Karam David Mulholland Carol Eng Hong Wu Min Song Oliver Dorigo

Purpose: This study evaluates the effect of dual PI3K and mTOR inhibition using NVP-BEZ235 in preclinical models of ovarian cancer as a potential novel therapeutic strategy. Experimental Design: Inhibition of PI3K/Akt/mTOR signaling by NVP-BEZ235 was demonstrated by immunoblotting. The effect on cell proliferation was assessed in 18 ovarian cancer cell lines, including four pairs of syngeneic c...

2012
Fatai A. Fehintola Kimberly K. Scarsi Qing Ma Sunil Parikh Gene D. Morse Babafemi Taiwo Ibrahim Tope Akinola Isaac F. Adewole Niklas Lindegardh Aphiradee Phakderaj Oladosu Ojengbede Robert L. Murphy Olusegun O. Akinyinka Francesca T. Aweeka

Background. Nevirapine- (NVP-) based antiretroviral therapy (ART) and artesunate-amodiaquine are frequently coprescribed in areas of HIV and malaria endemicity. We explored the impact of this practice on artesunate and dihydroartemisinin pharmacokinetics. Methods. We conducted a parallel-group pharmacokinetic comparison between HIV-infected patients receiving NVP-based ART (n = 10) and ART-naiv...

2012
Michele W. Tang Phyllis J. Kanki Robert W. Shafer

We systematically reviewed studies of the virological efficacy of the 4 new tenofovir (TDF)-containing regimens recommended for initial antiretroviral (ARV) therapy in the 2010 World Health Organization ARV Treatment Guidelines. Thirty-three studies assessed the efficacy of 1 or more TDF-containing regimens: TDF/lamivudine (3TC)/nevirapine (NVP) (n = 3), TDF/ emtricitabine (FTC)/NVP (n = 9), TD...

2013
Simbarashe Takuva Denise Evans Khangelani Zuma Velephi Okello Goedele Louwagie

Nevirapine (NVP) and Efavirenz (EFV) have generally comparable clinical and virologic efficacy. However, data comparing NVP durability to EFV are imprecise. We analyzed cohort data to compare durability of NVP to EFV among patients initiating ART in Mbabane, Swaziland. The primary outcome was poor regimen durability defined as any modification of NVP or EFV to the ART regimen. Multivariate Cox ...

Journal: :Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 2013
Thomas R Einarson Charles Piwko Gideon Koren

BACKGROUND Nausea and vomiting of pregnancy (NVP) is the most common medical condition in pregnancy, affecting women worldwide. It is unclear whether its prevalence and severity NVP are variable across different nations and races. PURPOSE To summarize global rates of NVP as reported in the literature using meta-analysis. METHODS We searched Medline, Embase and Cochrane databases for all pee...

2011
Keiko Shoji Katsutoshi Oda Tomoko Kashiyama Yuji Ikeda Shunsuke Nakagawa Kenbun Sone Yuichiro Miyamoto Haruko Hiraike Michihiro Tanikawa Aki Miyasaka Takahiro Koso Yoko Matsumoto Osamu Wada-Hiraike Kei Kawana Hiroyuki Kuramoto Frank McCormick Hiroyuki Aburatani Tetsu Yano Shiro Kozuma Yuji Taketani

5110 Background: PI3K (phosphatidylinositol-3-kinase) /mTOR (mammalian target of rapamycin) pathway is frequently activated in endometrial cancer through various PI3K/AKT activating genetic alterations, including mutations in PTEN, PIK3CA, and K-Ras. We evaluated the activity of a dual PI3K/mTOR.inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial cancer cell lines. METHODS We...

Journal: :Acta obstetricia et gynecologica Scandinavica 2003
Bengt Källén Gittan Lundberg Anders Aberg

BACKGROUND Nausea and vomiting in pregnancy (NVP) is a common complaint but risk factors for NVP are not well characterized. METHODS Occurrence of NVP was studied by questionnaires given to pregnant women at their first visit to the antenatal care unit and were returned around gestational week 28. RESULTS Analysis of 3675 completed questionnaires was made. Nausea and vomiting in pregnancy w...

2013
Svetlana Madjunkova Caroline Maltepe Gideon Koren

Background. Nausea and vomiting of pregnancy (NVP) is the most common medical condition of pregnancy, affecting up to 85% of expecting mothers. In the USA, there is no FDA-approved medication for the treatment of NVP. Objective. To identify the primary concerns of American women leading them to contact the Motherisk NVP Helpline and to characterize the severity of their symptoms and therapy off...

Journal: :Molecular cancer therapeutics 2012
Daniel L Menezes Pietro Taverna Michael R Jensen Tinya Abrams Darrin Stuart Guoying Karen Yu David Duhl Timothy Machajewski William R Sellers Nancy K Pryer Zhenhai Gao

A novel oral Hsp90 inhibitor, NVP-HSP990, has been developed and characterized in vitro and in vivo. In vitro, NVP-HSP990 exhibits single digit nanomolar IC(50) values on three of the Hsp90 isoforms (Hsp90α, Hsp90β, and GRP94) and 320 nanomolar IC(50) value on the fourth (TRAP-1), with selectivity against unrelated enzymes, receptors, and kinases. In c-Met amplified GTL-16 gastric tumor cells, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید